Anticoagulation

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22: P2Y12i Vs Aspirin Monotherapy in CAD Pts

Marco Valgimigli,

Watch time: 4:59
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli

Marco Valgimigli,

Watch time: 4:13

Watch time: 3:52:31

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3h 51m (47 videos)
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

George D Dangas, Adrian P Banning, Davide Cao, et al

Stuart J Head , Ad JJC Bogers , A Pieter Kappetein ,

Giulia Magnani , Marco Valgimigli ,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

Michael Haude ,

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3h 51m (47 videos)

George D Dangas, Adrian P Banning, Davide Cao, et al

Darshni Arishta Jhagroe , Jur ten Berg ,

Sri Raveen Kandan , Thomas W Johnson ,

Eunice NC Onwordi , Amr Gamal , Azfar Zaman ,

William R Colyer Jr , Christopher J Cooper ,

Michael Tsang , Sanjit Jolly ,

Anticoagulation after PCI in Atrial Fibrillation

Christopher P Cannon, Georg Nickenig,

Media

Watch time: 3:52:31
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall,

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

AHA 2019: Clinical Data Update on TWILIGHT and TWILIGHT-ACS

Marc P Bonaca, Roxana Mehran,

Media

View from the Thoraxcenter: ESC 22 Late-breaking Science Wrap-up

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 33:18
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3:29
ESC 22: P2Y12i Vs Aspirin Monotherapy in CAD Pts

Marco Valgimigli,

Watch time: 4:59
ESC 22: MASTER DAPT Results at 15M with Prof Valgimigli

Marco Valgimigli,

Watch time: 4:13

Watch time: 3:52:31

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 3h 51m (47 videos)
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24:27
View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap Up

Nicolas M Van Mieghem, Joost Daemen,

Justin Ezekowitz, Harriette Van Spall, Dylan L Steen, et al

ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

View from the Thoraxcanter: ACC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

George D Dangas, Adrian P Banning, Davide Cao, et al

TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type

George D Dangas,

RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients

Harald Thune Jorstad,

STOPDAPT-2 ACT: 1-month DAPT Followed by Clopidogrel Monotherapy in ACS

Hirotoshi Watanabe,

TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI

Davide Cao,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

EuroPCR 2021: Findings From the POEM Study

Giulio G Stefanini,

ACC 2021 Discussion: The ISCHEMIA Trial

Gregg Stone, Harriette Van Spall,

Tarv Dhanjal, Isabel Deisenhofer, John D Day, et al

John Eikelboom, Ken Okumura, Jan Steffel, et al

TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

TCT Connect 2020: The XIENCE 90/28 Trials

Roxana Mehran,

Jens Erik Nielsen Kudsk, A John Camm, Vivek Reddy, et al

Nicolas M Van Mieghem, Joost Daemen,

View from the Thoraxcenter – What's hot at ACC 2020

Nicolas M Van Mieghem, Joost Daemen,

CRT 2020: Duration of DAPT treatment in ST prevention

Dean J Kereiakes,

JIM 2020: Onyx ONE study

Gennaro Sardella,

BCIS ACI 2020: Update on DAPT

Robert F Storey,

AHA 2019: Updates from GALILEO-4D

Ole De Backer,

Articles

Antithrombotic Therapy After PCI in Patients Who Require OAC

Andrew Archbold

,

Citation:

Interventional Cardiology Review 2015;10(1):16–21

DOI:

https://doi.org/10.15420/icr.2015.10.1.16
  • Views: Views 1229
  • Downloads: Downloads 4

Contemporary Antiplatelet Strategies in the Treatment of STEMI using PPCI

Sri Raveen Kandan

,

Thomas W Johnson

,

Citation:

Interventional Cardiology Review 2015;10(1):26–31

DOI:

https://doi.org/10.15420/icr.2015.10.1.26
  • Views: Views 2973
  • Downloads: Downloads 14

Application in Hypertension of Renal Sympathetic Denervation - A Review

Dominik Linz

,

Felix Mahfoud

,

Sebastian Ewen

,

Stephan H Schirmer

,

Jan Reil

,

Christian Ukena

,

Citation:

Interventional Cardiology Review 2013;8(2):124-6

DOI:

https://doi.org/10.15420/icr.2013.8.2.124
  • Views: Views 430
  • Downloads: Downloads 3
  • Citations: 1

Catheter-based Renal Sympathetic Denervation - Long-term Symplicity™ Renal Denervation Clinical Evidence, New Data and Future Perspectives

Katrina Mountfort

,

Citation:

Interventional Cardiology Review 2013;8(2):118-23

DOI:

https://doi.org/10.15420/icr.2013.8.2.118
  • Views: Views 781
  • Downloads: Downloads 3
  • Citations: 5